A multi-center study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia: A real-life experience [Refrakter kronik immün trombositopeni tedavisinde eltrombopagın etkinliğine ilişkin çok merkezli bir çalışma: Gerçek y

Thumbnail
View/Open
Date
2019
Author
Çekdemir, D.
Güvenç, S.
Özdemirkıran, F.
Eser, A.
Toptaş, T.
Özkocaman, V.
Şahin, H.H.
Turak, E.E.
Esen, R.
Cömert, M.
Sadri, S.
Metadata
Show full item record
Abstract
Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP). Materials and Methods: A total of 285 chronic ITP patients (18
URI
https://doi.org/10.4274/tjh.galenos.2019.2018.0307
http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1269
Collections